APO Research
Talk to an analyst

APO RESEARCH · REPORT

Lipid Nanoparticle (LNP) Services

Compare research editions
View pricing & licenses

Selected research

Industry Research

Lipid Nanoparticle (LNP) Services Industry Research Report 2026

15 January 2026138 pages

Choose your research edition.

Industry ResearchLipid Nanoparticle (LNP) Services Industry Research Report 2026138 pages · $2,950 USDIndustry Growth & TrendsGlobal Lipid Nanoparticle (LNP) Services Industry Growth and Trends Forecast to 2032124 pages · $3,450 USDMarket StructureGlobal Lipid Nanoparticle (LNP) Services Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Lipid Nanoparticle (LNP) Services Market Outlook and Growth Opportunities 2026218 pages · $4,250 USDMarket Analysis & ForecastGlobal Lipid Nanoparticle (LNP) Services Market Analysis and Forecast 2026-2032211 pages · $4,950 USD

Market perspective

The global Lipid Nanoparticle (LNP) Services market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

North America: the Lipid Nanoparticle (LNP) Services market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Lipid Nanoparticle (LNP) Services market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Lipid Nanoparticle (LNP) Services market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Lipid Nanoparticle (LNP) Services include PreciGenome, Creative Biolabs, Genscript, ReciBioPharm, CD Bioparticles, Vernal Biosciences, Hzymes Biotech, LipExoGen and Evonik, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

Read the full market overview

This report quantifies the global Lipid Nanoparticle (LNP) Services market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Lipid Nanoparticle (LNP) Services.

Key Companies & Market Share Insights

This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Lipid Nanoparticle (LNP) Services Market by Company

PreciGenome

Creative Biolabs

Genscript

ReciBioPharm

CD Bioparticles

Vernal Biosciences

Hzymes Biotech

LipExoGen

Evonik

Merck

Cayman

Echelon

WuXi STA

BOC Sciences

Carcell

Cambridge Bioscience

FluidicLab

Guangzhou Anernor Biotechnology

Nanjing Yasmin Biotechnology

vectorbuilder

Helix Biotech

FUJIFILM Holdings

Ascendia Pharmaceuticals

Catalent

Polymun Scientific

Wacker

Corden Pharma

Cytiva

Croda International

Nippon Fine Chemical

Patheon

Lonza

Lipid Nanoparticle (LNP) Services Segment by Type

Formulation Service

Development Service

Others

Lipid Nanoparticle (LNP) Services Segment by Application

Drug Delivery

Diagnostics

Gene Therapy

Others

Lipid Nanoparticle (LNP) Services Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Spain

Russia

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Saudi Arabia

Israel

United Arab Emirates

Turkey

Iran

Egypt

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lipid Nanoparticle (LNP) Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Lipid Nanoparticle (LNP) Services and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lipid Nanoparticle (LNP) Services.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 6: Detailed analysis of Lipid Nanoparticle (LNP) Services companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 13: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Lipid Nanoparticle (LNP) Services Market Size by Type (2021-2026) & (US$ Million) Table 6. Global Lipid Nanoparticle (LNP) Services Revenue Market Share by Type (2021-2026) Table 7. Global Lipid Nanoparticle (LNP) Services Forecasted Market Size by Type (2027-2032) & (US$ Million) Table 8. Global Lipid Nanoparticle (LNP) Services Revenue Market Share by Type (2027-2032) Table 9. Global Lipid Nanoparticle (LNP) Services Market Size by Application (2021-2026) & (US$ Million) Table 10. Global Lipid Nanoparticle (LNP) Services Revenue Market Share by Application (2021-2026) Table 11. Global Lipid Nanoparticle (LNP) Services Forecasted Market Size by Application (2027-2032) & (US$ Million) Table 12. Global Lipid Nanoparticle (LNP) Services Revenue Market Share by Application (2027-2032) Table 13. Global Lipid Nanoparticle (LNP) Services Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Lipid Nanoparticle (LNP) Services Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Lipid Nanoparticle (LNP) Services Market Share by Region (2021-2026) Table 16. Global Lipid Nanoparticle (LNP) Services Forecasted Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Lipid Nanoparticle (LNP) Services Market Share by Region (2027-2032) Table 18. Lipid Nanoparticle (LNP) Services Industry Trends Table 19. Lipid Nanoparticle (LNP) Services Industry Drivers Table 20. Lipid Nanoparticle (LNP) Services Industry Opportunities and Challenges Table 21. Lipid Nanoparticle (LNP) Services Market Restraints Table 22. Global Top Lipid Nanoparticle (LNP) Services Players by Revenue (US$ Million) & (2021-2026) Table 23. Global Lipid Nanoparticle (LNP) Services Revenue Market Share by Players (2021-2026) Table 24. Global Lipid Nanoparticle (LNP) Services Industry Players Ranking, 2024 VS 2025 VS 2026 Table 25. Global Key Players of Lipid Nanoparticle (LNP) Services, Headquarters and Area Served Table 26. Global Lipid Nanoparticle (LNP) Services Players, Product Type & Application Table 27. Global Players Market Concentration Ratio (CR5 and HHI) Table 28. Global Lipid Nanoparticle (LNP) Services by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 29. Players Mergers & Acquisitions, Expansion Plans Table 30. North America Lipid Nanoparticle (LNP) Services Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 31. North America Lipid Nanoparticle (LNP) Services Market Size by Country (2021-2026) & (US$ Million) Table 32. North America Lipid Nanoparticle (LNP) Services Market Size by Country (2027-2032) & (US$ Million) Table 33. Europe Lipid Nanoparticle (LNP) Services Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Europe Lipid Nanoparticle (LNP) Services Market Size by Country (2021-2026) & (US$ Million) Table 35. Europe Lipid Nanoparticle (LNP) Services Market Size by Country (2027-2032) & (US$ Million) Table 36. Asia Pacific Lipid Nanoparticle (LNP) Services Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Asia Pacific Lipid Nanoparticle (LNP) Services Market Size by Region (2021-2026) & (US$ Million) Table 38. Asia Pacific Lipid Nanoparticle (LNP) Services Market Size by Country (2027-2032) & (US$ Million) Table 39. South America Lipid Nanoparticle (LNP) Services Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 40. South America Lipid Nanoparticle (LNP) Services Market Size by Country (2021-2026) & (US$ Million) Table 41. South America Lipid Nanoparticle (LNP) Services Market Size by Country (2027-2032) & (US$ Million) Table 42. Middle East & Africa Lipid Nanoparticle (LNP) Services Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 43. Middle East & Africa Lipid Nanoparticle (LNP) Services Market Size by Country (2021-2026) & (US$ Million) Table 44. Middle East & Africa Lipid Nanoparticle (LNP) Services Market Size by Country (2027-2032) & (US$ Million) Table 45. PreciGenome Company Information Table 46. PreciGenome Business Overview Table 47. PreciGenome Revenue in Lipid Nanoparticle (LNP) Services Business (2021-2026) & (US$ Million) Table 48. PreciGenome Lipid Nanoparticle (LNP) Services Product Portfolio Table 49. PreciGenome Recent Developments Table 50. Creative Biolabs Company Information Table 51. Creative Biolabs Business Overview Table 52. Creative Biolabs Revenue in Lipid Nanoparticle (LNP) Services Business (2021-2026) & (US$ Million) Table 53. Creative Biolabs Lipid Nanoparticle (LNP) Services Product Portfolio Table 54. Creative Biolabs Recent Developments Table 55. Genscript Company Information Table 56. Genscript Business Overview Table 57. Genscript Revenue in Lipid Nanoparticle (LNP) Services Business (2021-2026) & (US$ Million) Table 58. Genscript Lipid Nanoparticle (LNP) Services Product Portfolio Table 59. Genscript Recent Developments Table 60. ReciBioPharm Company Information Table 61. ReciBioPharm Business Overview Table 62. ReciBioPharm Revenue in Lipid Nanoparticle (LNP) Services Business (2021-2026) & (US$ Million) Table 63. ReciBioPharm Lipid Nanoparticle (LNP) Services Product Portfolio Table 64. ReciBioPharm Recent Developments Table 65. CD Bioparticles Company Information Table 66. CD Bioparticles Business Overview Table 67. CD Bioparticles Revenue in Lipid Nanoparticle (LNP) Services Business (2021-2026) & (US$ Million) Table 68. CD Bioparticles Lipid Nanoparticle (LNP) Services Product Portfolio Table 69. CD Bioparticles Recent Developments Table 70. Vernal Biosciences Company Information Table 71. Vernal Biosciences Business Overview Table 72. Vernal Biosciences Revenue in Lipid Nanoparticle (LNP) Services Business (2021-2026) & (US$ Million) Table 73. Vernal Biosciences Lipid Nanoparticle (LNP) Services Product Portfolio Table 74. Vernal Biosciences Recent Developments Table 75. Hzymes Biotech Company Information Table 76. Hzymes Biotech Business Overview Table 77. Hzymes Biotech Revenue in Lipid Nanoparticle (LNP) Services Business (2021-2026) & (US$ Million) Table 78. Hzymes Biotech Lipid Nanoparticle (LNP) Services Product Portfolio Table 79. Hzymes Biotech Recent Developments Table 80. LipExoGen Company Information Table 81. LipExoGen Business Overview Table 82. LipExoGen Revenue in Lipid Nanoparticle (LNP) Services Business (2021-2026) & (US$ Million) Table 83. LipExoGen Lipid Nanoparticle (LNP) Services Product Portfolio Table 84. LipExoGen Recent Developments Table 85. Evonik Company Information Table 86. Evonik Business Overview Table 87. Evonik Revenue in Lipid Nanoparticle (LNP) Services Business (2021-2026) & (US$ Million) Table 88. Evonik Lipid Nanoparticle (LNP) Services Product Portfolio Table 89. Evonik Recent Developments Table 90. Merck Company Information Table 91. Merck Business Overview Table 92. Merck Revenue in Lipid Nanoparticle (LNP) Services Business (2021-2026) & (US$ Million) Table 93. Merck Lipid Nanoparticle (LNP) Services Product Portfolio Table 94. Merck Recent Developments Table 95. Cayman Company Information Table 96. Cayman Business Overview Table 97. Cayman Revenue in Lipid Nanoparticle (LNP) Services Business (2021-2026) & (US$ Million) Table 98. Cayman Lipid Nanoparticle (LNP) Services Product Portfolio Table 99. Cayman Recent Developments Table 100. Echelon Company Information Table 101. Echelon Business Overview Table 102. Echelon Revenue in Lipid Nanoparticle (LNP) Services Business (2021-2026) & (US$ Million) Table 103. Echelon Lipid Nanoparticle (LNP) Services Product Portfolio Table 104. Echelon Recent Developments Table 105. WuXi STA Company Information Table 106. WuXi STA Business Overview Table 107. WuXi STA Revenue in Lipid Nanoparticle (LNP) Services Business (2021-2026) & (US$ Million) Table 108. WuXi STA Lipid Nanoparticle (LNP) Services Product Portfolio Table 109. WuXi STA Recent Developments Table 110. BOC Sciences Company Information Table 111. BOC Sciences Business Overview Table 112. BOC Sciences Revenue in Lipid Nanoparticle (LNP) Services Business (2021-2026) & (US$ Million) Table 113. BOC Sciences Lipid Nanoparticle (LNP) Services Product Portfolio Table 114. BOC Sciences Recent Developments Table 115. Carcell Company Information Table 116. Carcell Business Overview Table 117. Carcell Revenue in Lipid Nanoparticle (LNP) Services Business (2021-2026) & (US$ Million) Table 118. Carcell Lipid Nanoparticle (LNP) Services Product Portfolio Table 119. Carcell Recent Developments Table 120. Cambridge Bioscience Company Information Table 121. Cambridge Bioscience Business Overview Table 122. Cambridge Bioscience Revenue in Lipid Nanoparticle (LNP) Services Business (2021-2026) & (US$ Million) Table 123. Cambridge Bioscience Lipid Nanoparticle (LNP) Services Product Portfolio Table 124. Cambridge Bioscience Recent Developments Table 125. FluidicLab Company Information Table 126. FluidicLab Business Overview Table 127. FluidicLab Revenue in Lipid Nanoparticle (LNP) Services Business (2021-2026) & (US$ Million) Table 128. FluidicLab Lipid Nanoparticle (LNP) Services Product Portfolio Table 129. FluidicLab Recent Developments Table 130. Guangzhou Anernor Biotechnology Company Information Table 131. Guangzhou Anernor Biotechnology Business Overview Table 132. Guangzhou Anernor Biotechnology Revenue in Lipid Nanoparticle (LNP) Services Business (2021-2026) & (US$ Million) Table 133. Guangzhou Anernor Biotechnology Lipid Nanoparticle (LNP) Services Product Portfolio Table 134. Guangzhou Anernor Biotechnology Recent Developments Table 135. Nanjing Yasmin Biotechnology Company Information Table 136. Nanjing Yasmin Biotechnology Business Overview Table 137. Nanjing Yasmin Biotechnology Revenue in Lipid Nanoparticle (LNP) Services Business (2021-2026) & (US$ Million) Table 138. Nanjing Yasmin Biotechnology Lipid Nanoparticle (LNP) Services Product Portfolio Table 139. Nanjing Yasmin Biotechnology Recent Developments Table 140. vectorbuilder Company Information Table 141. vectorbuilder Business Overview Table 142. vectorbuilder Revenue in Lipid Nanoparticle (LNP) Services Business (2021-2026) & (US$ Million) Table 143. vectorbuilder Lipid Nanoparticle (LNP) Services Product Portfolio Table 144. vectorbuilder Recent Developments Table 145. Helix Biotech Company Information Table 146. Helix Biotech Business Overview Table 147. Helix Biotech Revenue in Lipid Nanoparticle (LNP) Services Business (2021-2026) & (US$ Million) Table 148. Helix Biotech Lipid Nanoparticle (LNP) Services Product Portfolio Table 149. Helix Biotech Recent Developments Table 150. FUJIFILM Holdings Company Information Table 151. FUJIFILM Holdings Business Overview Table 152. FUJIFILM Holdings Revenue in Lipid Nanoparticle (LNP) Services Business (2021-2026) & (US$ Million) Table 153. FUJIFILM Holdings Lipid Nanoparticle (LNP) Services Product Portfolio Table 154. FUJIFILM Holdings Recent Developments Table 155. Ascendia Pharmaceuticals Company Information Table 156. Ascendia Pharmaceuticals Business Overview Table 157. Ascendia Pharmaceuticals Revenue in Lipid Nanoparticle (LNP) Services Business (2021-2026) & (US$ Million) Table 158. Ascendia Pharmaceuticals Lipid Nanoparticle (LNP) Services Product Portfolio Table 159. Ascendia Pharmaceuticals Recent Developments Table 160. Catalent Company Information Table 161. Catalent Business Overview Table 162. Catalent Revenue in Lipid Nanoparticle (LNP) Services Business (2021-2026) & (US$ Million) Table 163. Catalent Lipid Nanoparticle (LNP) Services Product Portfolio Table 164. Catalent Recent Developments Table 165. Polymun Scientific Company Information Table 166. Polymun Scientific Business Overview Table 167. Polymun Scientific Revenue in Lipid Nanoparticle (LNP) Services Business (2021-2026) & (US$ Million) Table 168. Polymun Scientific Lipid Nanoparticle (LNP) Services Product Portfolio Table 169. Polymun Scientific Recent Developments Table 170. Wacker Company Information Table 171. Wacker Business Overview Table 172. Wacker Revenue in Lipid Nanoparticle (LNP) Services Business (2021-2026) & (US$ Million) Table 173. Wacker Lipid Nanoparticle (LNP) Services Product Portfolio Table 174. Wacker Recent Developments Table 175. Corden Pharma Company Information Table 176. Corden Pharma Business Overview Table 177. Corden Pharma Revenue in Lipid Nanoparticle (LNP) Services Business (2021-2026) & (US$ Million) Table 178. Corden Pharma Lipid Nanoparticle (LNP) Services Product Portfolio Table 179. Corden Pharma Recent Developments Table 180. Cytiva Company Information Table 181. Cytiva Business Overview Table 182. Cytiva Revenue in Lipid Nanoparticle (LNP) Services Business (2021-2026) & (US$ Million) Table 183. Cytiva Lipid Nanoparticle (LNP) Services Product Portfolio Table 184. Cytiva Recent Developments Table 185. Croda International Company Information Table 186. Croda International Business Overview Table 187. Croda International Revenue in Lipid Nanoparticle (LNP) Services Business (2021-2026) & (US$ Million) Table 188. Croda International Lipid Nanoparticle (LNP) Services Product Portfolio Table 189. Croda International Recent Developments Table 190. Nippon Fine Chemical Company Information Table 191. Nippon Fine Chemical Business Overview Table 192. Nippon Fine Chemical Revenue in Lipid Nanoparticle (LNP) Services Business (2021-2026) & (US$ Million) Table 193. Nippon Fine Chemical Lipid Nanoparticle (LNP) Services Product Portfolio Table 194. Nippon Fine Chemical Recent Developments Table 195. Patheon Company Information Table 196. Patheon Business Overview Table 197. Patheon Revenue in Lipid Nanoparticle (LNP) Services Business (2021-2026) & (US$ Million) Table 198. Patheon Lipid Nanoparticle (LNP) Services Product Portfolio Table 199. Patheon Recent Developments Table 200. Lonza Company Information Table 201. Lonza Business Overview Table 202. Lonza Revenue in Lipid Nanoparticle (LNP) Services Business (2021-2026) & (US$ Million) Table 203. Lonza Lipid Nanoparticle (LNP) Services Product Portfolio Table 204. Lonza Recent Developments Table 205. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Lipid Nanoparticle (LNP) Services Product Image Figure 5. Global Lipid Nanoparticle (LNP) Services Market Size Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 6. Global Lipid Nanoparticle (LNP) Services Market Share by Type: 2025 VS 2032 Figure 7. Formulation Service Product Figure 8. Development Service Product Figure 9. Others Product Figure 10. Global Lipid Nanoparticle (LNP) Services Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Lipid Nanoparticle (LNP) Services Market Share by Application: 2025 VS 2032 Figure 12. Drug Delivery Product Figure 13. Diagnostics Product Figure 14. Gene Therapy Product Figure 15. Others Product Figure 16. Global Lipid Nanoparticle (LNP) Services Market Size (US$ Million), Year-over-Year: 2021-2032 Figure 17. Global Lipid Nanoparticle (LNP) Services Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 18. Global Lipid Nanoparticle (LNP) Services Market Share by Region: 2025 VS 2032 Figure 19. Global Lipid Nanoparticle (LNP) Services Market Share by Players in 2025 Figure 20. Global Lipid Nanoparticle (LNP) Services Manufacturers Established Date Figure 21. Global Top 5 and 10 Lipid Nanoparticle (LNP) Services Players Market Share by Revenue in 2025 Figure 22. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. North America Lipid Nanoparticle (LNP) Services Market Size YoY Growth (2021-2032) & (US$ Million) Figure 24. North America Lipid Nanoparticle (LNP) Services Market Share by Country (2021-2032) Figure 25. United States Lipid Nanoparticle (LNP) Services Market Size YoY Growth (2021-2032) & (US$ Million) Figure 26. Canada Lipid Nanoparticle (LNP) Services Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Mexico Lipid Nanoparticle (LNP) Services Market Share by Country (2021-2032) Figure 28. Europe Lipid Nanoparticle (LNP) Services Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Europe Lipid Nanoparticle (LNP) Services Market Share by Country (2021-2032) Figure 30. Germany Lipid Nanoparticle (LNP) Services Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. France Lipid Nanoparticle (LNP) Services Market Size YoY Growth (2021-2032) & (US$ Million) Figure 32. U.K. Lipid Nanoparticle (LNP) Services Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Italy Lipid Nanoparticle (LNP) Services Market Size YoY Growth (2021-2032) & (US$ Million) Figure 34. Spain Lipid Nanoparticle (LNP) Services Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Russia Lipid Nanoparticle (LNP) Services Market Size YoY Growth (2021-2032) & (US$ Million) Figure 36. Netherlands Lipid Nanoparticle (LNP) Services Market Size YoY Growth (2021-2032) & (US$ Million) Figure 37. Nordic Countries Lipid Nanoparticle (LNP) Services Market Size YoY Growth (2021-2032) & (US$ Million) Figure 38. Asia-Pacific Lipid Nanoparticle (LNP) Services Market Size YoY Growth (2021-2032) & (US$ Million) Figure 39. Asia-Pacific Lipid Nanoparticle (LNP) Services Market Share by Country (2021-2032) Figure 40. China Lipid Nanoparticle (LNP) Services Market Size YoY Growth (2021-2032) & (US$ Million) Figure 41. Japan Lipid Nanoparticle (LNP) Services Market Size YoY Growth (2021-2032) & (US$ Million) Figure 42. South Korea Lipid Nanoparticle (LNP) Services Market Size YoY Growth (2021-2032) & (US$ Million) Figure 43. India Lipid Nanoparticle (LNP) Services Market Size YoY Growth (2021-2032) & (US$ Million) Figure 44. India Lipid Nanoparticle (LNP) Services Market Share by Country (2021-2032) Figure 45. Australia Lipid Nanoparticle (LNP) Services Market Size YoY Growth (2021-2032) & (US$ Million) Figure 46. China Taiwan Lipid Nanoparticle (LNP) Services Market Size YoY Growth (2021-2032) & (US$ Million) Figure 47. Southeast Asia Lipid Nanoparticle (LNP) Services Market Size YoY Growth (2021-2032) & (US$ Million) Figure 48. South America Lipid Nanoparticle (LNP) Services Market Size YoY Growth (2021-2032) & (US$ Million) Figure 49. South America Lipid Nanoparticle (LNP) Services Market Share by Country (2021-2032) Figure 50. Brazil Lipid Nanoparticle (LNP) Services Market Size YoY Growth (2021-2032) & (US$ Million) Figure 51. Argentina Lipid Nanoparticle (LNP) Services Market Size YoY Growth (2021-2032) & (US$ Million) Figure 52. Chile Lipid Nanoparticle (LNP) Services Market Size YoY Growth (2021-2032) & (US$ Million) Figure 53. Colombia Lipid Nanoparticle (LNP) Services Market Size YoY Growth (2021-2032) & (US$ Million) Figure 54. Peru Lipid Nanoparticle (LNP) Services Market Size YoY Growth (2021-2032) & (US$ Million) Figure 55. PreciGenome Revenue Growth Rate in Lipid Nanoparticle (LNP) Services Business (2021-2026) Figure 56. Creative Biolabs Revenue Growth Rate in Lipid Nanoparticle (LNP) Services Business (2021-2026) Figure 57. Genscript Revenue Growth Rate in Lipid Nanoparticle (LNP) Services Business (2021-2026) Figure 58. ReciBioPharm Revenue Growth Rate in Lipid Nanoparticle (LNP) Services Business (2021-2026) Figure 59. CD Bioparticles Revenue Growth Rate in Lipid Nanoparticle (LNP) Services Business (2021-2026) Figure 60. Vernal Biosciences Revenue Growth Rate in Lipid Nanoparticle (LNP) Services Business (2021-2026) Figure 61. Hzymes Biotech Revenue Growth Rate in Lipid Nanoparticle (LNP) Services Business (2021-2026) Figure 62. LipExoGen Revenue Growth Rate in Lipid Nanoparticle (LNP) Services Business (2021-2026) Figure 63. Evonik Revenue Growth Rate in Lipid Nanoparticle (LNP) Services Business (2021-2026) Figure 64. Merck Revenue Growth Rate in Lipid Nanoparticle (LNP) Services Business (2021-2026) Figure 65. Cayman Revenue Growth Rate in Lipid Nanoparticle (LNP) Services Business (2021-2026) Figure 66. Echelon Revenue Growth Rate in Lipid Nanoparticle (LNP) Services Business (2021-2026) Figure 67. WuXi STA Revenue Growth Rate in Lipid Nanoparticle (LNP) Services Business (2021-2026) Figure 68. BOC Sciences Revenue Growth Rate in Lipid Nanoparticle (LNP) Services Business (2021-2026) Figure 69. Carcell Revenue Growth Rate in Lipid Nanoparticle (LNP) Services Business (2021-2026) Figure 70. Cambridge Bioscience Revenue Growth Rate in Lipid Nanoparticle (LNP) Services Business (2021-2026) Figure 71. FluidicLab Revenue Growth Rate in Lipid Nanoparticle (LNP) Services Business (2021-2026) Figure 72. Guangzhou Anernor Biotechnology Revenue Growth Rate in Lipid Nanoparticle (LNP) Services Business (2021-2026) Figure 73. Nanjing Yasmin Biotechnology Revenue Growth Rate in Lipid Nanoparticle (LNP) Services Business (2021-2026) Figure 74. vectorbuilder Revenue Growth Rate in Lipid Nanoparticle (LNP) Services Business (2021-2026) Figure 75. Helix Biotech Revenue Growth Rate in Lipid Nanoparticle (LNP) Services Business (2021-2026) Figure 76. FUJIFILM Holdings Revenue Growth Rate in Lipid Nanoparticle (LNP) Services Business (2021-2026) Figure 77. Ascendia Pharmaceuticals Revenue Growth Rate in Lipid Nanoparticle (LNP) Services Business (2021-2026) Figure 78. Catalent Revenue Growth Rate in Lipid Nanoparticle (LNP) Services Business (2021-2026) Figure 79. Polymun Scientific Revenue Growth Rate in Lipid Nanoparticle (LNP) Services Business (2021-2026) Figure 80. Wacker Revenue Growth Rate in Lipid Nanoparticle (LNP) Services Business (2021-2026) Figure 81. Corden Pharma Revenue Growth Rate in Lipid Nanoparticle (LNP) Services Business (2021-2026) Figure 82. Cytiva Revenue Growth Rate in Lipid Nanoparticle (LNP) Services Business (2021-2026) Figure 83. Croda International Revenue Growth Rate in Lipid Nanoparticle (LNP) Services Business (2021-2026) Figure 84. Nippon Fine Chemical Revenue Growth Rate in Lipid Nanoparticle (LNP) Services Business (2021-2026) Figure 85. Patheon Revenue Growth Rate in Lipid Nanoparticle (LNP) Services Business (2021-2026) Figure 86. Lonza Revenue Growth Rate in Lipid Nanoparticle (LNP) Services Business (2021-2026)

Scope & coverage.

Types
  • Formulation Service
  • Development Service
  • Others
Applications
  • Drug Delivery
  • Diagnostics
  • Gene Therapy
  • Others
Companies covered
  • PreciGenome
  • Creative Biolabs
  • Genscript
  • ReciBioPharm
  • CD Bioparticles
  • Vernal Biosciences
  • Hzymes Biotech
  • LipExoGen
  • Evonik
  • Merck
  • Cayman
  • Echelon
  • WuXi STA
  • BOC Sciences
  • Carcell
  • Cambridge Bioscience
  • FluidicLab
  • Guangzhou Anernor Biotechnology
  • Nanjing Yasmin Biotechnology
  • vectorbuilder
  • Helix Biotech
  • FUJIFILM Holdings
  • Ascendia Pharmaceuticals
  • Catalent
  • Polymun Scientific
  • Wacker
  • Corden Pharma
  • Cytiva
  • Croda International
  • Nippon Fine Chemical
  • Patheon
  • Lonza

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Lipid Nanoparticle (LNP) Services by Type
  3. 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
  4. 2.2.2 Formulation Service
  5. 2.2.3 Development Service
  6. 2.2.4 Others
  7. 2.3 Lipid Nanoparticle (LNP) Services by Application
  8. 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  9. 2.3.2 Drug Delivery
  10. 2.3.3 Diagnostics
  11. 2.3.4 Gene Therapy
  12. 2.3.5 Others
  13. 2.4 Assumptions and Limitations
3 Lipid Nanoparticle (LNP) Services Breakdown Data by Type
  1. 3.1 Global Lipid Nanoparticle (LNP) Services Historic Market Size by Type (2021-2026)
  2. 3.2 Global Lipid Nanoparticle (LNP) Services Forecasted Market Size by Type (2027-2032)
4 Lipid Nanoparticle (LNP) Services Breakdown Data by Application
  1. 4.1 Global Lipid Nanoparticle (LNP) Services Historic Market Size by Application (2021-2026)
  2. 4.2 Global Lipid Nanoparticle (LNP) Services Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
  1. 5.1 Global Lipid Nanoparticle (LNP) Services Market Perspective (2021-2032)
  2. 5.2 Global Lipid Nanoparticle (LNP) Services Growth Trends by Region
  3. 5.2.1 Global Lipid Nanoparticle (LNP) Services Market Size by Region: 2021 VS 2025 VS 2032
  4. 5.2.2 Lipid Nanoparticle (LNP) Services Historic Market Size by Region (2021-2026)
  5. 5.2.3 Lipid Nanoparticle (LNP) Services Forecasted Market Size by Region (2027-2032)
  6. 5.3 Lipid Nanoparticle (LNP) Services Market Dynamics
  7. 5.3.1 Lipid Nanoparticle (LNP) Services Industry Trends
  8. 5.3.2 Lipid Nanoparticle (LNP) Services Market Drivers
  9. 5.3.3 Lipid Nanoparticle (LNP) Services Market Challenges
  10. 5.3.4 Lipid Nanoparticle (LNP) Services Market Restraints
6 Market Competitive Landscape by Players
  1. 6.1 Global Top Lipid Nanoparticle (LNP) Services Players by Revenue
  2. 6.1.1 Global Top Lipid Nanoparticle (LNP) Services Players by Revenue (2021-2026)
  3. 6.1.2 Global Lipid Nanoparticle (LNP) Services Revenue Market Share by Players (2021-2026)
  4. 6.2 Global Lipid Nanoparticle (LNP) Services Industry Players Ranking, 2023 VS 2024 VS 2025
  5. 6.3 Global Key Players of Lipid Nanoparticle (LNP) Services Head Office and Area Served
  6. 6.4 Global Lipid Nanoparticle (LNP) Services Players, Product Type & Application
  7. 6.5 Global Lipid Nanoparticle (LNP) Services Manufacturers Established Date
  8. 6.6 Global Lipid Nanoparticle (LNP) Services Market CR5 and HHI
  9. 6.7 Global Players Mergers & Acquisition
7 North America
  1. 7.1 North America Lipid Nanoparticle (LNP) Services Market Size (2021-2032)
  2. 7.2 North America Lipid Nanoparticle (LNP) Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 7.3 North America Lipid Nanoparticle (LNP) Services Market Size by Country (2021-2026)
  4. 7.4 North America Lipid Nanoparticle (LNP) Services Market Size by Country (2027-2032)
  5. 7.5 United States
  6. 7.5 United States
  7. 7.6 Canada
  8. 7.7 Mexico
8 Europe
  1. 8.1 Europe Lipid Nanoparticle (LNP) Services Market Size (2021-2032)
  2. 8.2 Europe Lipid Nanoparticle (LNP) Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 8.3 Europe Lipid Nanoparticle (LNP) Services Market Size by Country (2021-2026)
  4. 8.4 Europe Lipid Nanoparticle (LNP) Services Market Size by Country (2027-2032)
  5. 8.5 Germany
  6. 8.6 France
  7. 8.7 U.K.
  8. 8.8 Italy
  9. 8.9 Spain
  10. 8.10 Russia
  11. 8.11 Netherlands
  12. 8.12 Nordic Countries
9 Asia-Pacific
  1. 9.1 Asia-Pacific Lipid Nanoparticle (LNP) Services Market Size (2021-2032)
  2. 9.2 Asia-Pacific Lipid Nanoparticle (LNP) Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 9.3 Asia-Pacific Lipid Nanoparticle (LNP) Services Market Size by Country (2021-2026)
  4. 9.4 Asia-Pacific Lipid Nanoparticle (LNP) Services Market Size by Country (2027-2032)
  5. 9.5 China
  6. 9.6 Japan
  7. 9.7 South Korea
  8. 9.8 India
  9. 9.9 Australia
  10. 9.10 China Taiwan
  11. 9.11 Southeast Asia
10 South America
  1. 10.1 South America Lipid Nanoparticle (LNP) Services Market Size (2021-2032)
  2. 10.2 South America Lipid Nanoparticle (LNP) Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 10.3 South America Lipid Nanoparticle (LNP) Services Market Size by Country (2021-2026)
  4. 10.4 South America Lipid Nanoparticle (LNP) Services Market Size by Country (2027-2032)
  5. 10.5 Brazil
  6. 10.6 Argentina
  7. 10.7 Chile
  8. 10.8 Colombia
  9. 10.9 Peru
11 Middle East & Africa
  1. 11.1 Middle East & Africa Lipid Nanoparticle (LNP) Services Market Size (2021-2032)
  2. 11.2 Middle East & Africa Lipid Nanoparticle (LNP) Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 11.3 Middle East & Africa Lipid Nanoparticle (LNP) Services Market Size by Country (2021-2026)
  4. 11.4 Middle East & Africa Lipid Nanoparticle (LNP) Services Market Size by Country (2027-2032)
  5. 11.5 Saudi Arabia
  6. 11.6 Israel
  7. 11.7 United Arab Emirates
  8. 11.8 Turkey
  9. 11.9 Iran
  10. 11.10 Egypt
12 Players Profiled
  1. 12.1 PreciGenome
  2. 12.1.1 PreciGenome Company Information
  3. 12.1.2 PreciGenome Business Overview
  4. 12.1.3 PreciGenome Revenue in Lipid Nanoparticle (LNP) Services Business (2021-2026)
  5. 12.1.4 PreciGenome Lipid Nanoparticle (LNP) Services Product Portfolio
  6. 12.1.5 PreciGenome Recent Developments
  7. 12.2 Creative Biolabs
  8. 12.2.1 Creative Biolabs Company Information
  9. 12.2.2 Creative Biolabs Business Overview
  10. 12.2.3 Creative Biolabs Revenue in Lipid Nanoparticle (LNP) Services Business (2021-2026)
  11. 12.2.4 Creative Biolabs Lipid Nanoparticle (LNP) Services Product Portfolio
  12. 12.2.5 Creative Biolabs Recent Developments
  13. 12.3 Genscript
  14. 12.3.1 Genscript Company Information
  15. 12.3.2 Genscript Business Overview
  16. 12.3.3 Genscript Revenue in Lipid Nanoparticle (LNP) Services Business (2021-2026)
  17. 12.3.4 Genscript Lipid Nanoparticle (LNP) Services Product Portfolio
  18. 12.3.5 Genscript Recent Developments
  19. 12.4 ReciBioPharm
  20. 12.4.1 ReciBioPharm Company Information
  21. 12.4.2 ReciBioPharm Business Overview
  22. 12.4.3 ReciBioPharm Revenue in Lipid Nanoparticle (LNP) Services Business (2021-2026)
  23. 12.4.4 ReciBioPharm Lipid Nanoparticle (LNP) Services Product Portfolio
  24. 12.4.5 ReciBioPharm Recent Developments
  25. 12.5 CD Bioparticles
  26. 12.5.1 CD Bioparticles Company Information
  27. 12.5.2 CD Bioparticles Business Overview
  28. 12.5.3 CD Bioparticles Revenue in Lipid Nanoparticle (LNP) Services Business (2021-2026)
  29. 12.5.4 CD Bioparticles Lipid Nanoparticle (LNP) Services Product Portfolio
  30. 12.5.5 CD Bioparticles Recent Developments
  31. 12.6 Vernal Biosciences
  32. 12.6.1 Vernal Biosciences Company Information
  33. 12.6.2 Vernal Biosciences Business Overview
  34. 12.6.3 Vernal Biosciences Revenue in Lipid Nanoparticle (LNP) Services Business (2021-2026)
  35. 12.6.4 Vernal Biosciences Lipid Nanoparticle (LNP) Services Product Portfolio
  36. 12.6.5 Vernal Biosciences Recent Developments
  37. 12.7 Hzymes Biotech
  38. 12.7.1 Hzymes Biotech Company Information
  39. 12.7.2 Hzymes Biotech Business Overview
  40. 12.7.3 Hzymes Biotech Revenue in Lipid Nanoparticle (LNP) Services Business (2021-2026)
  41. 12.7.4 Hzymes Biotech Lipid Nanoparticle (LNP) Services Product Portfolio
  42. 12.7.5 Hzymes Biotech Recent Developments
  43. 12.8 LipExoGen
  44. 12.8.1 LipExoGen Company Information
  45. 12.8.2 LipExoGen Business Overview
  46. 12.8.3 LipExoGen Revenue in Lipid Nanoparticle (LNP) Services Business (2021-2026)
  47. 12.8.4 LipExoGen Lipid Nanoparticle (LNP) Services Product Portfolio
  48. 12.8.5 LipExoGen Recent Developments
  49. 12.9 Evonik
  50. 12.9.1 Evonik Company Information
  51. 12.9.2 Evonik Business Overview
  52. 12.9.3 Evonik Revenue in Lipid Nanoparticle (LNP) Services Business (2021-2026)
  53. 12.9.4 Evonik Lipid Nanoparticle (LNP) Services Product Portfolio
  54. 12.9.5 Evonik Recent Developments
  55. 12.10 Merck
  56. 12.10.1 Merck Company Information
  57. 12.10.2 Merck Business Overview
  58. 12.10.3 Merck Revenue in Lipid Nanoparticle (LNP) Services Business (2021-2026)
  59. 12.10.4 Merck Lipid Nanoparticle (LNP) Services Product Portfolio
  60. 12.10.5 Merck Recent Developments
  61. 12.11 Cayman
  62. 12.11.1 Cayman Company Information
  63. 12.11.2 Cayman Business Overview
  64. 12.11.3 Cayman Revenue in Lipid Nanoparticle (LNP) Services Business (2021-2026)
  65. 12.11.4 Cayman Lipid Nanoparticle (LNP) Services Product Portfolio
  66. 12.11.5 Cayman Recent Developments
  67. 12.12 Echelon
  68. 12.12.1 Echelon Company Information
  69. 12.12.2 Echelon Business Overview
  70. 12.12.3 Echelon Revenue in Lipid Nanoparticle (LNP) Services Business (2021-2026)
  71. 12.12.4 Echelon Lipid Nanoparticle (LNP) Services Product Portfolio
  72. 12.12.5 Echelon Recent Developments
  73. 12.13 WuXi STA
  74. 12.13.1 WuXi STA Company Information
  75. 12.13.2 WuXi STA Business Overview
  76. 12.13.3 WuXi STA Revenue in Lipid Nanoparticle (LNP) Services Business (2021-2026)
  77. 12.13.4 WuXi STA Lipid Nanoparticle (LNP) Services Product Portfolio
  78. 12.13.5 WuXi STA Recent Developments
  79. 12.14 BOC Sciences
  80. 12.14.1 BOC Sciences Company Information
  81. 12.14.2 BOC Sciences Business Overview
  82. 12.14.3 BOC Sciences Revenue in Lipid Nanoparticle (LNP) Services Business (2021-2026)
  83. 12.14.4 BOC Sciences Lipid Nanoparticle (LNP) Services Product Portfolio
  84. 12.14.5 BOC Sciences Recent Developments
  85. 12.15 Carcell
  86. 12.15.1 Carcell Company Information
  87. 12.15.2 Carcell Business Overview
  88. 12.15.3 Carcell Revenue in Lipid Nanoparticle (LNP) Services Business (2021-2026)
  89. 12.15.4 Carcell Lipid Nanoparticle (LNP) Services Product Portfolio
  90. 12.15.5 Carcell Recent Developments
  91. 12.16 Cambridge Bioscience
  92. 12.16.1 Cambridge Bioscience Company Information
  93. 12.16.2 Cambridge Bioscience Business Overview
  94. 12.16.3 Cambridge Bioscience Revenue in Lipid Nanoparticle (LNP) Services Business (2021-2026)
  95. 12.16.4 Cambridge Bioscience Lipid Nanoparticle (LNP) Services Product Portfolio
  96. 12.16.5 Cambridge Bioscience Recent Developments
  97. 12.17 FluidicLab
  98. 12.17.1 FluidicLab Company Information
  99. 12.17.2 FluidicLab Business Overview
  100. 12.17.3 FluidicLab Revenue in Lipid Nanoparticle (LNP) Services Business (2021-2026)
  101. 12.17.4 FluidicLab Lipid Nanoparticle (LNP) Services Product Portfolio
  102. 12.17.5 FluidicLab Recent Developments
  103. 12.18 Guangzhou Anernor Biotechnology
  104. 12.18.1 Guangzhou Anernor Biotechnology Company Information
  105. 12.18.2 Guangzhou Anernor Biotechnology Business Overview
  106. 12.18.3 Guangzhou Anernor Biotechnology Revenue in Lipid Nanoparticle (LNP) Services Business (2021-2026)
  107. 12.18.4 Guangzhou Anernor Biotechnology Lipid Nanoparticle (LNP) Services Product Portfolio
  108. 12.18.5 Guangzhou Anernor Biotechnology Recent Developments
  109. 12.19 Nanjing Yasmin Biotechnology
  110. 12.19.1 Nanjing Yasmin Biotechnology Company Information
  111. 12.19.2 Nanjing Yasmin Biotechnology Business Overview
  112. 12.19.3 Nanjing Yasmin Biotechnology Revenue in Lipid Nanoparticle (LNP) Services Business (2021-2026)
  113. 12.19.4 Nanjing Yasmin Biotechnology Lipid Nanoparticle (LNP) Services Product Portfolio
  114. 12.19.5 Nanjing Yasmin Biotechnology Recent Developments
  115. 12.20 vectorbuilder
  116. 12.20.1 vectorbuilder Company Information
  117. 12.20.2 vectorbuilder Business Overview
  118. 12.20.3 vectorbuilder Revenue in Lipid Nanoparticle (LNP) Services Business (2021-2026)
  119. 12.20.4 vectorbuilder Lipid Nanoparticle (LNP) Services Product Portfolio
  120. 12.20.5 vectorbuilder Recent Developments
  121. 12.21 Helix Biotech
  122. 12.21.1 Helix Biotech Company Information
  123. 12.21.2 Helix Biotech Business Overview
  124. 12.21.3 Helix Biotech Revenue in Lipid Nanoparticle (LNP) Services Business (2021-2026)
  125. 12.21.4 Helix Biotech Lipid Nanoparticle (LNP) Services Product Portfolio
  126. 12.21.5 Helix Biotech Recent Developments
  127. 12.22 FUJIFILM Holdings
  128. 12.22.1 FUJIFILM Holdings Company Information
  129. 12.22.2 FUJIFILM Holdings Business Overview
  130. 12.22.3 FUJIFILM Holdings Revenue in Lipid Nanoparticle (LNP) Services Business (2021-2026)
  131. 12.22.4 FUJIFILM Holdings Lipid Nanoparticle (LNP) Services Product Portfolio
  132. 12.22.5 FUJIFILM Holdings Recent Developments
  133. 12.23 Ascendia Pharmaceuticals
  134. 12.23.1 Ascendia Pharmaceuticals Company Information
  135. 12.23.2 Ascendia Pharmaceuticals Business Overview
  136. 12.23.3 Ascendia Pharmaceuticals Revenue in Lipid Nanoparticle (LNP) Services Business (2021-2026)
  137. 12.23.4 Ascendia Pharmaceuticals Lipid Nanoparticle (LNP) Services Product Portfolio
  138. 12.23.5 Ascendia Pharmaceuticals Recent Developments
  139. 12.24 Catalent
  140. 12.24.1 Catalent Company Information
  141. 12.24.2 Catalent Business Overview
  142. 12.24.3 Catalent Revenue in Lipid Nanoparticle (LNP) Services Business (2021-2026)
  143. 12.24.4 Catalent Lipid Nanoparticle (LNP) Services Product Portfolio
  144. 12.24.5 Catalent Recent Developments
  145. 12.25 Polymun Scientific
  146. 12.25.1 Polymun Scientific Company Information
  147. 12.25.2 Polymun Scientific Business Overview
  148. 12.25.3 Polymun Scientific Revenue in Lipid Nanoparticle (LNP) Services Business (2021-2026)
  149. 12.25.4 Polymun Scientific Lipid Nanoparticle (LNP) Services Product Portfolio
  150. 12.25.5 Polymun Scientific Recent Developments
  151. 12.26 Wacker
  152. 12.26.1 Wacker Company Information
  153. 12.26.2 Wacker Business Overview
  154. 12.26.3 Wacker Revenue in Lipid Nanoparticle (LNP) Services Business (2021-2026)
  155. 12.26.4 Wacker Lipid Nanoparticle (LNP) Services Product Portfolio
  156. 12.26.5 Wacker Recent Developments
  157. 12.27 Corden Pharma
  158. 12.27.1 Corden Pharma Company Information
  159. 12.27.2 Corden Pharma Business Overview
  160. 12.27.3 Corden Pharma Revenue in Lipid Nanoparticle (LNP) Services Business (2021-2026)
  161. 12.27.4 Corden Pharma Lipid Nanoparticle (LNP) Services Product Portfolio
  162. 12.27.5 Corden Pharma Recent Developments
  163. 12.28 Cytiva
  164. 12.28.1 Cytiva Company Information
  165. 12.28.2 Cytiva Business Overview
  166. 12.28.3 Cytiva Revenue in Lipid Nanoparticle (LNP) Services Business (2021-2026)
  167. 12.28.4 Cytiva Lipid Nanoparticle (LNP) Services Product Portfolio
  168. 12.28.5 Cytiva Recent Developments
  169. 12.29 Croda International
  170. 12.29.1 Croda International Company Information
  171. 12.29.2 Croda International Business Overview
  172. 12.29.3 Croda International Revenue in Lipid Nanoparticle (LNP) Services Business (2021-2026)
  173. 12.29.4 Croda International Lipid Nanoparticle (LNP) Services Product Portfolio
  174. 12.29.5 Croda International Recent Developments
  175. 12.30 Nippon Fine Chemical
  176. 12.30.1 Nippon Fine Chemical Company Information
  177. 12.30.2 Nippon Fine Chemical Business Overview
  178. 12.30.3 Nippon Fine Chemical Revenue in Lipid Nanoparticle (LNP) Services Business (2021-2026)
  179. 12.30.4 Nippon Fine Chemical Lipid Nanoparticle (LNP) Services Product Portfolio
  180. 12.30.5 Nippon Fine Chemical Recent Developments
  181. 12.31 Patheon
  182. 12.31.1 Patheon Company Information
  183. 12.31.2 Patheon Business Overview
  184. 12.31.3 Patheon Revenue in Lipid Nanoparticle (LNP) Services Business (2021-2026)
  185. 12.31.4 Patheon Lipid Nanoparticle (LNP) Services Product Portfolio
  186. 12.31.5 Patheon Recent Developments
  187. 12.32 Lonza
  188. 12.32.1 Lonza Company Information
  189. 12.32.2 Lonza Business Overview
  190. 12.32.3 Lonza Revenue in Lipid Nanoparticle (LNP) Services Business (2021-2026)
  191. 12.32.4 Lonza Lipid Nanoparticle (LNP) Services Product Portfolio
  192. 12.32.5 Lonza Recent Developments
13 Report Conclusion
    14 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst